Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Jamf Holding $538.2 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $538.2 million initial public…
Berkeley Lights $204.9 million IPO
Davis Polk advised the underwriters in connection with an initial public offering of 9,315,000 shares of common stock of…
Google investment in Reliance Industries’ Jio Platforms unit
Davis Polk is advising Reliance Industries Limited and Jio Platforms Limited in connection with binding agreements entered…
Inventiva $108 million U.S. IPO and Nasdaq listing
Davis Polk advised the representatives of the underwriters in connection with an initial public offering of Inventiva S…
Royalty Pharma $2.5 billion IPO
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering…
Generation Bio $230 million IPO
Davis Polk advised the representatives of the underwriters in connection with the $230 million initial public offering…
Novo Nordisk $725 million acquisition of Corvidia Therapeutics
Davis Polk is advising Novo Nordisk A/S on its acquisition of Corvidia Therapeutics Inc. for an upfront payment of $725…
Legend Biotech $487 million IPO
Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend…
Warner Music Group $1.925 billion IPO
Davis Polk advised the representatives of the several underwriters, in connection with the $1.925 billion initial…
ADC Therapeutics $267 million IPO
Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which…